Physician profile
Jason Cooper
NPI 1326041484
$1,605.90
in general payments reported to CMS, 2019-2025
24 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $47.88 · 2021: $152 · 2022: $308 · 2023: $264 · 2024: $236 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $350.01 | 2019-2022 | |
| Medtronic, INC. | $175.98 | 2023-2025 | Venaseal, V-Loc 180 |
| Astellas Pharma US INC | $158.02 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $118.14 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $111.13 | 2021-2023 | |
| Hologic Sales and Service, LLC | $105.51 | 2023-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Coopersurgical, INC. | $69.74 | 2021-2024 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Pfizer INC. | $68.78 | 2022-2024 | |
| Myovant Sciences INC. | $68.27 | 2022 | |
| Renovia INC | $51.53 | 2019 | |
| Agile Therapeutics, INC. | $44.05 | 2021-2022 | |
| Exact Sciences Corporation | $34.48 | 2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $29.07 | 2024 | Ova1 |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Sage Therapeutics, LLC | $27.83 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $24.77 | 2024 | Slynd |
| Millicent US INC | $21.46 | 2019 | |
| Novo Nordisk INC | $20.57 | 2025 | Rybelsus, Ozempic |
| Organon LLC | $19.77 | 2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $16.79 | 2021 | |
| Medicem INC. | $16.64 | 2022 | |
| Mayne Pharma Commercial LLC | $16.18 | 2024 | |
| Vertical Pharmaceuticals, LLC | $14.89 | 2019 | |
| Avion Pharmaceuticals | $13.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.